Literature DB >> 9117179

The Nottingham Health Profile as a measure of disease activity and outcome in rheumatoid arthritis.

D A Houssien1, S P McKenna, D L Scott.   

Abstract

Clinical measurement in rheumatoid arthritis (RA) has focused on articular problems. Although measures like the Health Assessment Questionnaire (HAQ) are widely used to determine functional impairment, there is a need to determine the overall effect of RA on general health status. We evaluated the relationship of a generic health status measure-the Nottingham Health Profile (NHP)-to the clinical, laboratory and radiological changes in the EULAR core data set for RA. Two hundred consecutive out-patients with RA were recruited. Their mean age was 58.9 yr and mean disease duration 11.3 yr. Patients completed the NHP and the following assessments were made: the EULAR Core Data Set, the duration of morning stiffness, the Disease Activity Score (DAS), rheumatoid factor (RF) levels, and Larsen's score for X-rays of hands and wrists. RA patients had higher scores on the NHP than both a random population sample and a second sample of patients with a variety of common diseases. NHP scores were not related to age or disease duration in RA. There was little relationship between perceived distress and the Larsen score, RF, ESR and C-reactive protein levels. Moderate associations were seen between NHP scores and disease activity measures, including the number of tender and swollen joints, pain and the duration of early morning stiffness, and also with a disability measure-the HAQ. NHP scores were highly related to disease activity measured by DAS. High DAS scores were associated with high scores in the energy level, pain and sleep sections of the NHP. The NHP gives relevant information about RA patients. They have high scores for pain, physical mobility and energy level sections, and also have high distress for sleep and emotional reactions.

Entities:  

Mesh:

Year:  1997        PMID: 9117179     DOI: 10.1093/rheumatology/36.1.69

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  16 in total

Review 1.  A primer on lower extremity outcome measurement instruments.

Authors:  C L Saltzman; C Mueller; K Zwior-Maron; R D Hoffman
Journal:  Iowa Orthop J       Date:  1998

2.  Quality of life of patients with rheumatoid arthritis in Argentina: reliability, validity, and sensitivity to change of a Spanish version of the Rheumatoid Arthritis Quality of Life questionnaire.

Authors:  Christian A Waimann; Fernando M Dal Pra; Maria F Marengo; Emilce E Schneeberger; Susana Gagliardi; Jose A Maldonado Cocco; Mónica Sanchez; A Garone; Rafael E Chaparro del Moral; Oscar L Rillo; Mariana Salcedo; Javier E Rosa; F Ceballos; Enrique R Soriano; Gustavo Citera
Journal:  Clin Rheumatol       Date:  2012-04-04       Impact factor: 2.980

3.  Health-related quality of life in rheumatoid arthritis: comparison of RAQoL with other scales in terms of disease activity, severity of pain, and functional status.

Authors:  Yesim Garip; Filiz Eser; Hatice Bodur
Journal:  Rheumatol Int       Date:  2010-02-24       Impact factor: 2.631

Review 4.  Measuring the effects of medication use on health-related quality of life in patients with rheumatoid arthritis. A review.

Authors:  M B Nichol; A S Harada
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981

5.  Quality of life in patients with Takayasu's arteritis is impaired and comparable with rheumatoid arthritis and ankylosing spondylitis patients.

Authors:  Servet Akar; Gercek Can; Omer Binicier; Kenan Aksu; Baris Akinci; Dilek Solmaz; Merih Birlik; Gökhan Keser; Nurullah Akkoc; Fatos Onen
Journal:  Clin Rheumatol       Date:  2007-12-21       Impact factor: 2.980

6.  The Nottingham Health Profile in rheumatoid arthritis: correlation with other health status measurements and clinical variables.

Authors:  F Sivas; O Erçin; O Tanyolaç; N Barça; S Aydoğ; K Ozoran
Journal:  Rheumatol Int       Date:  2003-08-27       Impact factor: 2.631

7.  A comparison of four different HRQoL generic questionnaire in five different patient groups.

Authors:  Lale Akbulut Aktekin; Filiz Eser; Simten Malhan; Ergun Öksüz; Dilek Keskin; Hatice Bodur
Journal:  Rheumatol Int       Date:  2009-11       Impact factor: 2.631

Review 8.  Challenges comparing functional limitations in rheumatoid arthritis and ankylosing spondylitis.

Authors:  G H Louie; J D Reveille; M M Ward
Journal:  Clin Exp Rheumatol       Date:  2009 Jul-Aug       Impact factor: 4.473

Review 9.  Patient-reported outcomes and their role in the assessment of rheumatoid arthritis.

Authors:  Deborah P Lubeck
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

10.  Anti-Citrullinated Cyclic Peptide Antibody and Functional Disability Are Associated With Poor Sleep Quality in Rheumatoid Arthritis.

Authors:  Shamala Rajalingam; Rajalingham Sakthiswary; Heselynn Hussein
Journal:  Arch Rheumatol       Date:  2016-12-08       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.